The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model

Nephrology Dialysis Transplantation

Volumn 17, Issue 11, 2002, Pages 1950-1956

  Cole, Louise ^a   Bellomo, Rinaldo ^a   Davenport, Piers ^b   Tipping, Peter ^b   Uchino, Shigehiko ^a   Tetta, Ciro ^c   Ronco, Claudio ^d  

^a AUSTIN HEALTH   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c Cyberonics Inc   (Italy)

^d SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Adsorption; Charcoal cartridge; Ex vivo model; Haemofiltration; Inflammatory cytokines

Indexed keywords

ACTIVATED CARBON; CYTOKINE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; POLYSULFONE; TUMOR NECROSIS FACTOR; AUTACOID; CHARCOAL;

ADSORPTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HOSPITAL; HUMAN; HUMAN EXPERIMENT; INCUBATION TIME; INFLAMMATION; INTENSIVE CARE UNIT; NORMAL HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; STATISTICAL MODEL; ULTRAFILTRATION; BLOOD; CHEMISTRY; EQUIPMENT DESIGN; INSTRUMENTATION; ISOLATION AND PURIFICATION; MOLECULAR WEIGHT; OSMOLARITY;

ADSORPTION; CHARCOAL; CYTOKINES; EQUIPMENT DESIGN; HEMOFILTRATION; HUMANS; INFLAMMATION MEDIATORS; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION;

EID: 0036843898     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.11.1950     Document Type: Article

References (14)

1. Schetz M. Non-renal indications for continuous renal replacement therapy. Kidney Int 1999; 56 [Suppl 72]: S88-S94
2. Schetz M. Evidence-based analysis of the use of hemofiltration in sepsis and MODS. Curr Opin Intens Care 1997; 3: 434-441
3. De Vriese AS, Vanholder RC, Pascual M et al. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intens Care Med 1999; 25: 903-910
4. Tetta C, Cavaillon JM, Schulze M et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 1998; 13: 1458-1464
5. Jaber BL, Pereira BJG. Extracorporeal adsorbent-based strategies in sepsis. Am J Kidney Dis 1997; 30 [Suppl 4]: S44-S56
6. Bouman CSC, van Olden RW, Stontenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 1998; 16: 261-268
7. De Vriese AS, Colardyn FA, Philippe JJ et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-853
8. Webb LMC, Ehrengruber MU, Clark-Lewis I et al. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 1993; 90: 7158-7162
9. Amato M, Cozzolino F, Bergesio F et al. A. In-vitro interleukin-1 production by different dialysis membranes. Nephrol Dial Transplant 1988; 3: 432-434
10. Nagaki M, Hughes RD, Lau JYN et al. Removal of endotoxin and cytokines by adsorbents and the effect of plasma protein binding. Int J Artif Organs 1991; 14: 43-50
11. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101-195
12. David S, Cambi V. Hemofiltration: predilution versus post-dilution. In: Shaldon S, Koch KM, eds. Polyamide: the Evolution of a Synthetic Membrane for Renal Therapy. Contrib Nephrol. Karger, Basel, 1992; 77-85
13. De Francisco ALM, Ghezzi PM, Brendolan A et al. Hemodiafiltration with online regeneration of the ultrafiltrate. Kidney Int 2000; 58 [Suppl 76]: S66-S71
14. Leypoldt JK, Jørstad S, Frigon RP et al. Temperature dependence of macromolecular sieving across plasma fractionating membranes. ASAIO Transactions 1988; 34: 4201-4224